The global artificial intelligence (AI) in breast imaging market size accounted for USD 493.11 million in 2024, grew to USD 573.49 million in 2025, and is expected to be worth around USD 2,232.25 million by 2034, poised to grow at a CAGR of 16.3% between 2024 and 2034. The North America artificial intelligence (AI) in breast imaging market size is predicted to increase from USD 157.80 million in 2024 and is estimated to grow at the fastest CAGR of 16.48% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Intelligence (AI) in Breast Imaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Intelligence (AI) in Breast Imaging Market, By End-Use, 2024-2034
8.1.1. Hospitals
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Ambulatory Surgical Centers
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Specialty Clinics & Trauma Centers
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.1.2. U.S.
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.2.3. France
9.2.3.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.2.4. Rest of Europe
9.2.4.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, By End-Use (2021-2034)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, By End-Use (2021-2034)
10.1. GE Healthcare
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Hologic, Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Gamma Medica, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Siemens Healthcare
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Fujifilm Holdings Corp.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Toshiba Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Aurora Imaging Technology, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample